Evolution Biotechnologies | 2016 February
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Evolution Biotechnologies announces completion of initial funding round and appointment of Chief Operating Officer Evolution Biotehnologies (www.evolutionbiotech.com), the UK-based company established to expand the use of biological control into medically important areas, today announced the closure of its first funding round, having raised the full sum sought at this time. The investment will support the establishment of the company’s development streams and central corporate facility ahead of further funding rounds. Further announcements on staff appointments and activities are planned for the near future. The company also announced the appointment of Mr. Aaron Gunn to the board and to the post of Chief...